Calquence Is A Bruton Tyrosine Kinase (Btk) Inhibitor Indicated For The Treatment Of Adult Patients With Mantle Cell Lymphoma (Mcl) Who Have Received At Least One Prior Therapy.
Vowst Is A Prescription Medicine Used To Prevent Clostridioides Difficile (C. Diff) Infection From Coming Back In People 18 Years Of Age Or Older After Antibiotic Treatment For C. Diff Infection Has Been Completed.
Zepbound® Is Indicated As An Adjunct To A Reduced-Calorie Diet And Increased Physical Activity For Chronic Weight Management In Adults With An Initial Body Mass Index (Bmi) Of: 30 Kg/M2 Or Greater (Obesity) Or 27 Kg/M2 Or Greater (Overweight) In The Presence Of At Least One Weight-Related Comorbid Condition (E.G., Hypertension, Dyslipidemia, Type 2 Diabetes Mellitus, Obstructive Sleep Apnea, Or Cardiovascular Disease
Nextevo Naturals Water Soluble Cbd Is Made With 100% All-Natural Us-Grown Hemp And Is Independently Lab-Tested Throughout Every Stage Of Its Formulation To Ensure Purity And Potency. Our Pure, Highly Concentrated Cbd Is Also Gmo-Free, Gluten-Free, And Suitable For Vegan Diets.
Mounjaro (Tirzepatide), An Injectable Prescription Medicine, Is Indicated As An Adjunct To Diet And Exercise To Improve Glycemic Control In Adults With Type 2 Diabetes Mellitus.
Hizentra®, Immune Globulin Subcutaneous (Human), 20% Liquid, Is Indicated For Treatment Of Primary Immunodeficiency (Pi) In Adults And Pediatric Patients 2 Years And Older. Maintenance Therapy In Adults With Chronic Inflammatory Demyelinating Polyneuropathy (Cidp) To Prevent Relapse Of Neuromuscular Disability And Impairment. Limitation Of Use: Maintenance Therapy In Cidp Has Been Systematically Studied For 6 Months And For A Further 12 Months In A Follow-Up Study.
Leqembi Is Indicated For The Treatment Of Alzheimer’S Disease. Treatment With Leqembi Should Be Initiated In Patients With Mild Cognitive Impairment Or Mild Dementia Stage Of Disease, The Population In Which Treatment Was Initiated In Clinical Trials.
Indications Cabometyx® (Cabozantinib), In Combination With Nivolumab, Is Indicated For The First-Line Treatment Of Patients With Advanced Renal Cell Carcinoma (Rcc). Cabometyx Is Indicated For The Treatment Of Patients With Advanced Rcc. Cabometyx Is Indicated For The Treatment Of Patients With Hepatocellular Carcinoma (Hcc) Who Have Been Previously Treated With Sorafenib. Cabometyx Is Indicated For The Treatment Of Adult And Pediatric Patients 12 Years Of Age And Older With Local
Abilify Maintena Is An Atypical Antipsychotic Indicated For: • Treatment Of Schizophrenia In Adults • Maintenance Monotherapy Treatment Of Bipolar I Disorder In Adults
Quviviq Is An Orexin Receptor Antagonist Indicated For The Treatment Of Adult Patients With Insomnia, Characterized By Difficulties With Sleep Onset And/Or Sleep Maintenance.
Vyepti (Eptinezumab-Jjmr) Is Indicated For The Preventive Treatment Of Migraine In Adults.
Privigen Is Indicated For The Treatment Of Chronic Inflammatory Demyelinating Polyneuropathy (Cidp) In Adults. Limitation Of Use: Maintenance Therapy In Cidp Has Not Been Studied For Periods Longer Than 6 Months. Individualize Duration Of Treatment Beyond 6 Months Based On Patient Response.
Taltz® Is A Humanized Interleukin-17A Antagonist Indicated For The Treatment Of: • Patients Aged 6 Years Or Older With Moderate-To-Severe Plaque Psoriasis Who Are Candidates For Systemic Therapy Or Phototherapy. • Adults With Active Psoriatic Arthritis. • Adults With Active Ankylosing Spondylitis. • Adults With Active Non-Radiographic Axial Spondyloarthritis With Objective Signs Of Inflammation.
Stelara® (Ustekinumab) Is Indicated For The Treatment Of Adult Patients With Moderately To Severely Active Crohn's Disease Or Moderately To Severely Active Ulcerative Colitis.
Apretude Is Indicated In At-Risk Adults And Adolescents Weighing At Least 35 Kg For Pre-Exposure Prophylaxis (Prep) To Reduce The Risk Of Sexually Acquired Hiv-1 Infection. Individuals Must Have A Negative Hiv-1 Test Prior To Initiating Apretude (With Or Without An Oral Lead-In With Oral Cabotegravir) For Hiv-1 Prep.
Libtayo Is Indicated For The Treatment Of Patients With Metastatic Cutaneous Squamous Cell Carcinoma (Cscc) Or Locally Advanced Cscc Who Are Not Candidates For Curative Surgery Or Curative Radiation.
Auvelity Is Indicated For The Treatment Of Major Depressive Disorder (Mdd) In Adults.
Brukinsa® (Zanubrutinib) Is A Kinase Inhibitor Indicated For The Treatment Of Adult Patients With: Waldenström’S Macroglobulinemia (Wm). Mantle Cell Lymphoma (Mcl) Who Have Received At Least One Prior Therapy. Relapsed Or Refractory Marginal Zone Lymphoma (Mzl) Who Have Received At Least One Anti-Cd20-Based Regimen.
Jaypirca Is A Kinase Inhibitor Indicated For The Treatment Of Adult Patients With Relapsed Or Refractory (R/R) Mantle Cell Lymphoma (Mcl) After At Least Two Lines Of Systemic Therapy, Including A Btk Inhibitor.
Nucala Is An Interleukin-5 (Il-5) Antagonist Monoclonal Antibody (Igg1 Kappa) Indicated For: • Add-On Maintenance Treatment Of Adult And Pediatric Patients Aged 6 Years And Older With Severe Asthma And With An Eosinophilic Phenotype. • Add-On Maintenance Treatment Of Adult Patients 18 Years And Older With Chronic Rhinosinusitis With Nasal Polyps (Crswnp). • The Treatment Of Adult Patients With Eosinophilic Granulomatosis With Polyangiitis (Egpa). • The Treatment Of Adult And Pediatric Pat
Zeposia® (Ozanimod) Is Indicated For The Treatment Of Moderately To Severely Active Ulcerative Colitis (Uc) In Adults.
Tibsovo Is An Isocitrate Dehydrogenase-1 (Idh1) Inhibitor Indicated For The Treatment Of Adult Patients With A Susceptible Idh1 Mutation As Detected By An Fda-Approved Test With: Acute Myeloid Leukemia (Aml) Newly-Diagnosed Aml Who Are = 75 Years Old Or Who Have Comorbidities That Preclude Use Of Intensive Induction Chemotherapy. Relapsed Or Refractory Aml. Locally Advanced Or Metastatic Cholangiocarcinoma Locally Advanced Or Metastatic Cholangiocarcinoma Who Have Been Previous